Evidence map›Paper›PMID 19534466›Full record

ArticleJournal of the American Chemical Society2009

A non-chromatographic method for the purification of a bivalently active monoclonal IgG antibody from biological fluids.

Başar Bilgiçer, Samuel W Thomas, Bryan F Shaw, George K Kaufman, Vijay M Krishnamurthy, Lara A Estroff, Jerry Yang, George M Whitesides

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Redox Dual-Responsive and OTheranostics · 2019
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Başar BilgiçerDepartment of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.
Samuel W Thomas
Bryan F Shaw
George K Kaufman
Vijay M Krishnamurthy
Lara A Estroff
Jerry Yang
George M Whitesides
Harvard University · US

Funding

Multivalency: Mechanisms and ApplicationsR01GM030367 · NIGMS · HARVARD UNIVERSITY · PI WHITESIDES, GEORGE M · 1985 to 2010
$3.0M
ENZYMES AS CATALYSTS IN THE SYNTHESIS OF CARBOHYDRATESR37GM030367 · NIGMS · HARVARD UNIVERSITY · PI WHITESIDES, GEORGE M · 1991 to 2000
$572k
Bio-Inspired Synthesis and Assembly of NanocrystalsF32EB003361 · NIBIB · HARVARD UNIVERSITY · PI ESTROFF, LARA A · 2003 to 2004
$77k
NIBIB NIH HHS F32 EB003361NIGMS NIH HHS GM 30367NIGMS NIH HHS R01 GM030367NIGMS NIH HHS R37 GM030367
6 · The paper itself

Abstract

This paper describes a method for the purification of monoclonal antibodies (rat anti-2,4-dinitrophenyl IgG: IgG(DNP); and mouse antidigoxin IgG: IgG(Dgn)) from ascites fluid. This procedure (for IgG(DNP)) has three steps: (i) precipitation of proteins heavier than immunoglobulins with ammonium sulfate; (ii) formation of cyclic complexes of IgG(DNP) by causing it to bind to synthetic multivalent haptens containing multiple DNP groups; (iii) selective precipitation of these dimers, trimers, and higher oligomers of the target antibody, followed by regeneration of the free antibody. This procedure separates the targeted antibody from a mixture of antibodies, as well as from other proteins and globulins in a biological fluid. This method is applicable to antibodies with a wide range of monovalent binding constants (0.1 microM to 0.1 nM). The multivalent ligands we used (derivatives of DNP and digoxin) isolated IgG(DNP) and IgG(Dgn) from ascites fluid in yields of >80% and with >95% purity. This technique has two advantages over conventional chromatographic methods for purifying antibodies: (i) it is selective for antibodies with two active Fab binding sites (both sites are required to form the cyclic complexes) over antibodies with one or zero active Fab binding sites; (ii) it does not require chromatographic separation. It has the disadvantage that the structure of the hapten must be compatible with the synthesis of bi- and/or trivalent analogues.

Indexed as

Ammonium SulfateAnimalsAntibodies, MonoclonalAscitesBinding Sites, AntibodyChemical PrecipitationChromatography, GelDigoxinDimerizationDinitrobenzenesHaptensImmunoglobulin GMiceModels, MolecularRatsAmmonium SulfateAntibodies, MonoclonalDigoxinDinitrobenzenesHaptensImmunoglobulin G

Identifiers

PMID19534466
PMCPMC2845436
OpenAlexW1991525756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.